Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells

British Journal of Cancer

Volumn 97, Issue 7, 2007, Pages 941-948

  Zvereff, V ^a,e   Wang, J C ^a,f   Shun, K ^a   Lacoste, J ^b   Chevrette, M ^a,c,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e Thallion Pharmaceuticals Inc   (Canada)

^f MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

CD9; Mitotic catastrophe; Mortalin; Prostate; Senescence

Indexed keywords

CD9 ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GROWTH; CELL CULTURE; CELL FUSION; CELL INTERACTION; CELL MIGRATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN INTERACTION;

ANTIGENS, CD; CELL MEMBRANE; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MALE; MEMBRANE GLYCOPROTEINS; MITOSIS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 34948891532     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603964     Document Type: Article

References (52)

1. Berditchevski F, Odintsova E (1999) Characterization of integrin-tetraspanin adhesion complexes: Role of tetraspanins in integrin signaling. J Cell Biol 146: 477-492
2. Boucheix C, Silvie O, Rubinstein E, Mazier D (2004) A tiny thread towards a tetraspanin function. Pathol Biol 52: 55-57
3. Cajot JF, Sordat I, Silvestre T, Sordat B (1997) Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res 57: 2593-2597
4. Charrin S, Manie S, Billard M, Ashman L, Gerlier D, Boucheix C, Rubinstein E (2003) Multiple levels of interactions within the tetraspanin web. Biochem Biophys Res Commun 304: 107-112
5. Chen TR (1977) In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst-33258 stain. Exp Cell Res 104: 255-262
6. Cohen-Jonathan E, Bernhard EJ, McKenna WG (1999) How does radiation kill cells? Curr Opin Chem Biol 3: 77-83
7. Demidenko ZN, Blagosklonny MV (2004) Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor. Cancer Res 64: 3653-3660
8. Dundas SR, Lawrie LC, Rooney PH, Murray GI (2005) Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol 205: 74-81
9. Erovic BM, Pammer J, Hollemann D, Woegerbauer M, Geleff S, Fischer MB, Burian M, Frommlet F, Neuchrist C (2003) Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Head & Neck 25: 848-857
10. Hemler ME (2001) Specific tetraspanin functions. J Cell Biol 155: 1103-1107
11. Higashiyama M, Kodama K, Yokouchi H, Takami K, Adachi M, Taki T, Ishiguro S, Nakamori S, Yoshie O, Miyake M (1998) KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor - An immunohistochemical analysis. Cancer 83: 466-474
12. Hori H, Yano S, Koufuji K, Takeda J, Shirouzo K (2004) CD9 expression in gastric cancer and its significance. J Surg Res 117: 208-215
13. Ibi T, Sahashi K, Ling J, Marui K, Mitsuma T (1996) Immunostaining of mitochondrial heat shock proteins (mtHSPs) in skeletal muscle fibers of mitochondrial cytopathy. Clin Neurol 36: 61-64
14. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M (1993) Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177: 1231-1237
15. Isaacs WB, Carter BS, Ewing CM (1991) Wild type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 51: 4716-4720
16. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L (1996) Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56: 816-825
17. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23
18. Kaul SC, Duncan E, Sugihara T, Reddel RR, Mitsui Y, Wadhwa R (2000a) Structurally and functionally distinct mouse hsp70 family members Mot-1 and Mot-2 proteins are encoded by two alleles. DNA Res 7: 229-231
19. Kaul SC, Duncan EL, Englezou A, Takano S, Reddel RR, Mitsui Y, Wadhwa R (1998) Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein. Oncogene 17: 907-911
20. Kaul SC, Reddel RR, Sugihara T, Mitsui Y, Wadhwa R (2000b) Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2. Febs Lett 474: 159-164
21. Kaul SC, Taira K, Pereira-Smith OM, Wadhwa R (2002) Mortalin: present and prospective. Exp Gerontol 37: 1157-1164
22. Kaul Z, Yaguchi T, Kaul SC, Wadhwa R (2006) Quantum dot-based protein imaging and functional significance of two mitochondrial chaperones in cellular senescence and carcinogenesis. Ann NY Acad Sci 1067: 469-473
23. Kovalenko OV, Yang XW, Kolesnikova TV, Hemler ME (2004) Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking. Biochem J 377: 407-417
24. Le Naour F, Andre M, Greco C, Billard M, Sordat B, Emile JF, Lanza F, Boucheix C, Rubinstein E (2006) Profiling of the tetraspanin web of human colon cancer cells. Mol & Cell Proteom 5: 845-857
25. Lock RB, Stribinskiene L (1996) Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 56: 4006-4012
26. Maecker HT, Todd SC, Levy S (1997) The tetraspanin superfamily: Molecular facilitators. FASEB J 11: 428-442
27. Miyake M, Koyama M, Seno M, Ikeyama S (1991) Identification of the motility related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 174: 1347-1354
28. Miyake M, Nakano K, Itoi S, Koh T, Taki T (1996) Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 56: 1244-1249
29. Mizukoshi E, Suzuki M, Misono T, Loupatov A, Munekata E, Kaul SC, Wadhwa R, Imamura T (2001) Cell-cycle dependent tyrosine phosphorylation on mortalin regulates its interaction with fibroblast growth factor-1. Biochem Biophys Res Commun 280: 1203-1209
30. Ornatsky OI, Connor MK, Hood DA (1995) Expression of stress proteins and mitochondrial chaperonins in chronically stimulated skeletal muscle. Biochem J 311: 119-123
31. Pereira-Smith OM, Smith JR (1988) Genetic analysis of indefinite division in human cells - Identification of 4 complementation groups. Proc Natl Acad Sci USA 85: 6042-6046
32. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ (1996) Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2: 1627-1636
33. Ran QT, Wadhwa R, Kawai R, Kaul SC, Sifers RN, Bick RJ, Smith JR, Pereira-Smith OM (2000) Extramitochondrial localization of mortalin/mthsp70/ PBP74/GRP75. Biochem Biophys Res Commun 275: 174-179
34. Roninson IB, Broude EV, Chang BD (2001) If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 4: 303-313
35. Schneider JJ, Hood DA (2000) Effect of thyroid hormone on mthsp70 expression, mitochondrial import and processing in cardiac muscle. J Endocrinol 165: 9-17
36. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281
37. Takahashi S, Mikami T, Watanabe Y, Okazaki M, Okazaki Y, Okazaki A, Sato T, Asaishi K, Hirata K, Narimatsu E, Mori M, Sato N, Kikuchi I (1994) Correlation of heat shock protein-70 expression with estrogen receptor levels in invasive human breast cancer. Am J Clin Pathol 101: 519-525
38. Takano S, Wadhwa R, Yoshii Y, Nose T, Kaul SC, Mitsui Y (1997) Elevated levels of mortalin expression in human brain tumors. Exp Cell Res 237: 38-45
39. Torres K, Horwitz SB (1998) Mechanisms of taxol-induced cell death are concentration dependent. Cancer Res 58: 3620-3626
40. Tounekti O, Pron G, Belehradek Jr J, Mir LM (1993) Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53: 5462-5469
41. Uchida S, Shimada Y, Watanabe G, Li ZG, Miyake M, Imamura M (1999) Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 79: 1168-1173
42. Wadhwa R, Ando H, Kawasaki H, Taira K, Kaul SC (2003) Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes. EMBO Reports 4: 595-601
43. Wadhwa R, Kaul SC, Ikawa Y, Sugimoto Y (1993a) Identification of a novel member of mouse hsp70 family - its association with cellular mortal phenotype. J Biol Chem 268: 6615-6621
44. Wadhwa R, Kaul SC, Sugimoto Y, Mitsui Y (1993b) Induction of cellular senescence by transfection of cytosolic mortalin cDNA in NIH-3T3 cells. J Biol Chem 268: 22239-22242
45. Wadhwa R, Pereira-Smith OM, Reddel RR, Sugimoto Y, Mitsui Y, Kaul SC (1995) Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp Cell Res 216: 101-106
46. Wadhwa R, Takano S, Kaur K, Deocaris CC, Pereira-Smith OM, Reddel RR, Kaul SC (2006) Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer 118: 2973-2980
47. Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR, Mitsui Y, Kaul SC (1998) Inactivation of tumor suppressor p53 by Mot-2, a hsp70 family member. J Biol Chem 273: 29586-29591
48. Wadhwa R, Takano S, Taira K, Kaul SC (2004) Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells. J Gene Med 6: 439-444
49. Wang JC, Begin LR, Berube NG, Chevalier S, Aprikian AG, Gourdeau H, Chevrette M (2007) Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Clin Cancer Res 13: 2354-2361
50. Xu J, Xiao HH, Sartorelli AC (1999) Attenuation of the induced differentiation of HL-60 leukemia cells by mitochondrial chaperone HSP70. Oncol Res 11: 429-435
51. Yau JC, Dabbagh LK, Formenti KS, Coupland RW, Burns BF, Shaw AR (1998) Expression of transmembrane 4 superfamily member, CD9, is related to improved progression-free survival in patients with diffuse non-Hodgkin's lymphoma. Oncol Rep 5: 1507-1511
52. Zvieriev V, Wang JC, Chevrette M (2005) Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells. Biochem Biophys Res Commun 337: 498-504